- Tytuł:
- Early skeletal muscle mass decline is a prognostic factor in patients receiving gemcitabine plus nab-paclitaxel for unresectable pancreatic cancer: a retrospective observational study
- Autorzy:
- Źródło:
- Supportive Care in Cancer. 31(3)
Czasopismo naukowe